SCIENTURE HOLDINGS, INC. Fair Value of Assets Acquired
SCIENTURE HOLDINGS, INC. (SCNX) reported Fair Value of Assets Acquired of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-02.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueOfAssetsAcquired · last filed 2018-03-02
- SCIENTURE HOLDINGS, INC. fair value of assets acquired for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- SCIENTURE HOLDINGS, INC. fair value of assets acquired for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- SCIENTURE HOLDINGS, INC. fair value of assets acquired for the quarter ending 2016-12-31 was $43.98K.
- SCIENTURE HOLDINGS, INC. fair value of assets acquired for the quarter ending 2016-09-30 was $71.70K.
- SCIENTURE HOLDINGS, INC. fair value of assets acquired for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- SCIENTURE HOLDINGS, INC. fair value of assets acquired for fiscal 2016 was $171.46K.
| Period end | Fair Value of Assets Acquired 3 month | Fair Value of Assets Acquired 6 month | Fair Value of Assets Acquired 9 month | Fair Value of Assets Acquired 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | $0.00 derived: sum of 2 quarters · filed 2018-03-02 | $0.00 10-K · filed 2018-03-02 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $0.00 10-Q · filed 2017-11-07 | ||
| 2017-06-30 | $0.00 10-Q · filed 2017-08-04 | |||
| 2016-12-31 | $43.98K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | $115.68K derived: sum of 2 quarters · filed 2018-03-02 | $171.46K 10-K · filed 2018-03-02 | |
| 2016-09-30 | $71.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $127.48K 10-Q · filed 2017-11-07 | ||
| 2016-06-30 | $55.78K 10-Q · filed 2017-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |